Pancreatic Cancer Research

ResearcherWayne State UniversityActive in the last 2 years

Steve H. Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9950-1232; OpenAlex author ID A5089628525. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 6

  1. Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2025.11.21.689857↗
  2. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Co-author DOI 10.1002/ctm2.1513↗
  3. Potentially curative resection of an abdominal wall metastasis from pancreatic adenocarcinoma: a case report. Last author DOI 10.1093/jscr/rjac138↗
  4. Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer … Co-author DOI 10.1101/2022.03.08.481108↗
  5. Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-1728↗
  6. Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Co-author DOI 10.3390/cancers12030750↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Husain Yar Khan · 5 shared papers, 2020–2025 · strength 0.63
  2. Amro Aboukameel · 5 shared papers, 2020–2025 · strength 0.63
  3. Asfar Sohail Azmi · 5 shared papers, 2020–2025 · strength 0.63
  4. Sahar F. Bannoura · 3 shared papers, 2022–2025 · strength 0.44
  5. Md. Hafiz Uddin · 3 shared papers, 2022–2025 · strength 0.44
  6. Anthony Frank Shields · 3 shared papers, 2022–2025 · strength 0.44
  7. Ramzi M. Mohammad · 3 shared papers, 2020–2025 · strength 0.36
  8. Philip A. Philip · 3 shared papers, 2020–2023 · strength 0.33
  9. Tanya Odisho · 2 shared papers, 2022–2023 · strength 0.33
  10. Yiwei Li · 2 shared papers, 2022–2023 · strength 0.27
  11. Rachel E. Sexton · 2 shared papers, 2020–2022 · strength 0.22
  12. Anteneh A. Tesfaye · 2 shared papers, 2020 · strength 0.19
  13. Mandana Kamgar · 2 shared papers, 2020 · strength 0.19
  14. P. A. Philip · 1 shared paper, 2025 · strength 0.17
  15. Bin Bao · 1 shared paper, 2025 · strength 0.17
  16. Boris Pasche · 1 shared paper, 2025 · strength 0.17
  17. Eliza Wright Beal · 1 shared paper, 2025 · strength 0.17
  18. Muhammad Wasif Saif · 1 shared paper, 2025 · strength 0.17
  19. Azeddine Atfi · 1 shared paper, 2025 · strength 0.17
  20. Bassel F. El‐Rayes · 1 shared paper, 2025 · strength 0.17
  21. Ibrahim Hanna Azar · 1 shared paper, 2023 · strength 0.14
  22. Irfana Muqbil · 1 shared paper, 2020 · strength 0.09
  23. Maria Diab · 1 shared paper, 2020 · strength 0.09
  24. Amit Mahipal · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.